Checchi Capital Advisers’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $342K | Sell |
4,308
-121
| -3% | -$9.11K | 0.02% | 450 |
|
|
2026
Q1 | $333K | Buy |
4,429
+157
| +4% | +$12.4K | 0.02% | 452 |
|
|
2025
Q4 | $338K | Buy |
4,272
+39
| +0.9% | +$2.94K | 0.02% | 409 |
|
|
2025
Q3 | $277K | Buy |
+4,233
| New | +$207K | 0.01% | 462 |
|
|
2024
Q3 | – | Sell |
-4,234
| Closed | -$202K | – | 589 |
|
|
2024
Q2 | $202K | Buy |
+4,234
| New | +$174K | 0.01% | 542 |
|
|
2024
Q1 | – | Sell |
-4,234
| Closed | -$214K | – | 587 |
|
|
2023
Q4 | $214K | Buy |
+4,234
| New | +$203K | 0.02% | 516 |
|
|
2021
Q1 | – | Sell |
-4,369
| Closed | -$247K | – | 531 |
|
|
2020
Q4 | $247K | Sell |
4,369
-19
| -0.4% | -$947 | 0.03% | 400 |
|
|
2020
Q3 | $208K | Sell |
4,388
-340
| -7% | -$18.9K | 0.02% | 401 |
|
|
2020
Q2 | $279K | Buy |
4,728
+388
| +9% | +$21.6K | 0.03% | 322 |
|
|
2020
Q1 | $205K | Buy |
4,340
+926
| +27% | +$51.6K | 0.02% | 335 |
|
|
2019
Q4 | $206K | Sell |
3,414
-564
| -14% | -$33.6K | 0.03% | 409 |
|
|
2019
Q3 | $238K | Sell |
3,978
-2,439
| -38% | -$159K | 0.03% | 355 |
|
|
2019
Q2 | $412K | Sell |
6,417
-417
| -6% | -$29.5K | 0.05% | 231 |
|
|
2019
Q1 | $555K | Buy |
6,834
+438
| +7% | +$28.3K | 0.06% | 171 |
|
|
2018
Q4 | $346K | Hold |
6,396
| – | – | 0.04% | 234 |
|
|
2018
Q3 | $330K | Sell |
6,396
-2
| -0% | -$94 | 0.04% | 295 |
|
|
2018
Q2 | $267K | Sell |
6,398
-1,115
| -15% | -$49.4K | 0.03% | 324 |
|
|
2018
Q1 | $331K | Sell |
7,513
-4,949
| -40% | -$251K | 0.04% | 275 |
|
|
2017
Q4 | $627K | Sell |
12,462
-5,361
| -30% | -$294K | 0.08% | 162 |
|
|
2017
Q3 | $904K | Hold |
17,823
| – | – | 0.09% | 99 |
|
|
2017
Q2 | $907K | Hold |
17,823
| – | – | 0.1% | 96 |
|
|
2017
Q1 | $716K | Sell |
17,823
-500
| -3% | -$22.5K | 0.08% | 129 |
|
|
2016
Q4 | $876K | Sell |
18,323
-3,862
| -17% | -$153K | 0.12% | 100 |
|
|
2016
Q3 | $813K | Buy |
22,185
+192
| +0.9% | +$6.01K | 0.09% | 103 |
|
|
2016
Q2 | $512K | Buy |
21,993
+712
| +3% | +$23K | 0.06% | 144 |
|
|
2016
Q1 | $862K | Hold |
21,281
| – | – | 0.19% | 87 |
|
|
2015
Q4 | $1.32M | Buy |
21,281
+27
| +0.1% | +$1.46K | 0.33% | 63 |
|
|
2015
Q3 | $859K | Sell |
21,254
-1,605
| -7% | -$83.1K | 0.23% | 83 |
|
|
2015
Q2 | $1.32M | Buy |
+22,859
| New | +$1.45M | 0.35% | 62 |
|
Other funds holding IONS
Checchi Capital Advisers's IONS Position: Q2 2026 in Review
Checchi Capital Advisers reduced its Ionis Pharmaceuticals (IONS) stake by 2.7% in Q2 2026, selling an estimated $9.11K and leaving 4,308 shares worth $342K. The position accounts for 0.02% of the portfolio, ranked #450.
Checchi Capital Advisers first reported a position in IONS in Q2 2015 and has held it in 29 quarters since. The position peaked at $1.32M in Q4 2015. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.
- Checchi Capital Advisers held 4,308 shares of Ionis Pharmaceuticals worth $342K as of Q2 2026.
- Checchi Capital Advisers sold 121 Ionis Pharmaceuticals shares in Q2 2026, an estimated $9.11K.
- Ionis Pharmaceuticals made up 0.02% of Checchi Capital Advisers's portfolio in Q2 2026, its #450 holding.
- Checchi Capital Advisers first reported a position in Ionis Pharmaceuticals in Q2 2015 and has held it in 29 quarters since.
- Checchi Capital Advisers's Ionis Pharmaceuticals position peaked at $1.32M in Q4 2015.
- 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.
Based on Checchi Capital Advisers's 13F filing for Q2 2026, filed 4 Aug 2026.